Erkihun Mulat, Ayele Bayu, Asmare Zelalem, Endalamaw Kirubel
Department of Medical Laboratory Sciences, School of Health Sciences, College of Medicine and Health Sciences Debre Tabor University Debre Tabor Ethiopia.
Laboratory Service Unit Felege Hiwot Comprehensive Specialized Hospital Bahir Dar Ethiopia.
Health Sci Rep. 2024 Nov 4;7(11):e70166. doi: 10.1002/hsr2.70166. eCollection 2024 Nov.
Coronavirus disease 2019 is caused by the severe acute respiratory syndrome coronavirus 2, which has become a pandemic. Severe acute respiratory syndrome coronavirus 2 is an enveloped, unsegmented, positive-sense, single-stranded RNA virus that belongs to the family Coronaviridae.
The objective of this review is to conduct a qualitative analysis of the current updates on epidemiology, evolution, and vaccine variants for SARS-CoV-2.
The search strategy was done from the database based on the PRISMA criteria for qualitative analysis of this review. Literature on variants of severe acute respiratory syndrome coronavirus 2, published in English in the last 5 years (2019-2023), were included. From 179 a total of 105 articles were reviewed, searched, and retrieved from the electronic databases PubMed. The search was done using keywords like COVID-19, SARS-CoV-2, variants, mutations, and vaccines, and articles were managed using EndNote X8 software. The scope of view for this review was the course of the pandemic by emerging variants and how man is struggling to overcome this sudden pandemic through vaccines. The narrative skeleton was constructed based on the article's scope of view.
From the parent severe acute respiratory syndrome coronavirus 2, many variants emerged during the course of this pandemic. They are mainly categorized into two variants: variants of interest and variants of concern based on the impact on public health. The World Health Organization leveled five variants: Alpha (strain B.1.1.7), Beta (strain B.1.351), Gamma (strain P.1), Delta (strain B.1.617.2), and Omicron (B.1.1.529).
It is crucial to stay informed about the latest developments in the understanding of SARS-CoV-2 variants, as new variants can emerge and impact the course of the pandemic. Health authorities and researchers continuously have to monitor and study these variants to assess their characteristics, transmissibility, severity, and the effectiveness of vaccines against them. One has to always refer to the latest information from reputable health journals or organizations for the most up-to-date and accurate details on COVID-19 variants.
2019冠状病毒病由严重急性呼吸综合征冠状病毒2引起,该疾病已成为全球大流行疾病。严重急性呼吸综合征冠状病毒2是一种包膜、不分节段、正链、单链RNA病毒,属于冠状病毒科。
本综述的目的是对严重急性呼吸综合征冠状病毒2的流行病学、进化和疫苗变异的当前最新情况进行定性分析。
根据本综述定性分析的PRISMA标准,从数据库中进行检索。纳入过去5年(2019 - 2023年)以英文发表的关于严重急性呼吸综合征冠状病毒2变异株的文献。从总共179篇文章中,对105篇进行了综述、检索并从电子数据库PubMed中获取。检索使用了如COVID - 19、SARS - CoV - 2、变异株、突变和疫苗等关键词,并使用EndNote X8软件管理文章。本综述的视野范围是新兴变异株在大流行过程中的情况以及人类如何通过疫苗努力克服这场突发的大流行。根据文章的视野范围构建了叙述框架。
在这场大流行过程中,从原始的严重急性呼吸综合征冠状病毒2出现了许多变异株。根据对公共卫生的影响,它们主要分为两类变异株:关注变异株和关切变异株。世界卫生组织将5种变异株进行了分级:阿尔法(B.1.1.7毒株)、贝塔(B.1.351毒株)、伽马(P.1毒株)、德尔塔(B.1.617.2毒株)和奥密克戎(B.1.1.529)。
了解严重急性呼吸综合征冠状病毒2变异株的最新进展至关重要,因为新的变异株可能出现并影响大流行的进程。卫生当局和研究人员必须持续监测和研究这些变异株,以评估它们的特征、传播性、严重性以及针对它们的疫苗的有效性。人们必须始终参考知名健康期刊或组织的最新信息,以获取关于COVID - 19变异株的最新和准确细节。